Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection
- 27 July 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 31 (4), 547-556
- https://doi.org/10.1007/s10096-011-1346-3
Abstract
The purpose of this paper was to prospectively characterize the clinical manifestations and outcomes of confirmed influenza A 2009 (H1N1) virus infection in immunosuppressed patients with hospital admission and compare them with those of a general population. A multicenter prospective cohort study was carried out. All adult patients admitted to 13 hospitals in Spain with confirmed influenza A 2009 (H1N1) virus infection from June 12, 2009 to November 11, 2009 were included. Risk factors for complicated influenza infection were studied in immunosuppressed patients. Overall, 559 patients were included, of which 56 were immunosuppressed, nine with solid or hematological malignancies, 18 with solid-organ transplant recipients, 13 with corticosteroid therapy, and six with other types of immunosuppression. Clinical findings at diagnosis were similar in both groups. Nineteen immunosuppressed patients had pneumonia (33.9%). Immunosuppressed patients with pandemic influenza had bacterial co-infection more frequently (17.9% vs. 6.4%, p = 0.02), specifically, gram-negative bacilli and Staphylococcus aureus infections. Mortality was higher in immunosuppressed patients (7.1% vs. 1.8%, p < 0.05). The only modifiable risk factor of complicated influenza A 2009 (H1N1) was delayed antiviral therapy. In immunosuppressed patients, influenza A 2009 (H1N1) virus infection has higher mortality than in non-immunosuppressed individuals. Bacterial co-infection is common in complicated cases.Keywords
This publication has 26 references indexed in Scilit:
- Impact of Corticosteroid Treatment and Antiviral Therapy on Clinical Outcomes in Hematopoietic Cell Transplant Patients Infected with Influenza VirusTransplantation and Cellular Therapy, 2011
- Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort studyThe Lancet Infectious Diseases, 2010
- Risk of severe outcomes among patients admitted to hospital with pandemic (H1N1) influenzaCMAJ : Canadian Medical Association Journal, 2010
- Hospitalized Patients with 2009 H1N1 Influenza in the United States, April–June 2009New England Journal of Medicine, 2009
- Clinical characteristics of paediatric H1N1 admissions in Birmingham, UKThe Lancet, 2009
- Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in HumansNew England Journal of Medicine, 2009
- The challenge of respiratory virus infections in hematopoietic cell transplant recipientsBritish Journal of Haematology, 2008
- Antiviral Treatment for Patients Hospitalized with Severe Influenza Infection May Affect Clinical OutcomesClinical Infectious Diseases, 2008
- Respiratory virus infection among hematopoietic cell transplant recipients: evidence for asymptomatic parainfluenza virus infectionBlood, 2007
- Influenza A in Immunocompromised PatientsClinical Infectious Diseases, 1993